Netherlands· NL-ec4ca2451a76
Pylobactell-13C Ureum-100 mg oplosbare tablet- sachet met één oplosbare tablet, in een meerdere componenten bevattend proefpakket-oraal gebruik
A other diagnostic agents product containing ureum c13, registered in Netherlands by Richen Europe S.R.L.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ureum c13 is registered in 11 of 19 countries.
Countries holding a registration under ATC V04CX (other diagnostic agents), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Ureum c13 · ATC V04CX
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- UREUM C13
- Manufacturer
- Richen Europe S.R.L.
- Country
- Netherlands (NL)
- ATC code
- V04CX
- ATC class
- Other diagnostic agents
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/98/064
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V04CX
Other diagnostic agents, as other registers publish it.
- CzechiaAPULCOAir Products spol. s r.o., Děčín
- CzechiaAPULCOAir Products spol. s r.o., Děčín
- CzechiaAPULCOAir Products spol. s r.o., Děčín
- CzechiaAPULCOAir Products spol. s r.o., Děčín
- NetherlandsApulco Acometh 0,30%/0,30%/0,30%, medicinaal gas, samengeperstAir Products Nederland B.V.
- NetherlandsApulco CoHe 0,28%/9,5%, medicinaal gas, samengeperstAir Products Nederland B.V.
- NetherlandsApulco CoHeMax 0,28%/14%, medicinaal gas, samengeperstAir Products Nederland B.V.
- NetherlandsApulco He 9%, medicinaal gas, samengeperstAir Products Nederland B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eacef166-b0cc-4680-9e3c-f0d0aecf8ebb GET /v1/drugs/eacef166-b0cc-4680-9e3c-f0d0aecf8ebb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplosbare tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/pylobactell-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Other Diagnostic Agents",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70157",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"NATRIUMBENZOAAT (E 211)",
"POVIDON (E 1201)",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"UREUM C13"
],
"leaflet_url": null,
"authorised_at": "1998/05/07",
"procedure_number": "EMEA/H/C/000151",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/98/064",
"additional_monitoring": "N"
}See everything about ureum c13.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.